Autor: G. Mathe

G.MATHE Institut de Cancerologie et d’Immunogenetique (INSERM et Association Claude-Bernad), H6pital Paul-Brousse and Institute Gustave-Roussy, Villejuif 20 years ago, the main, if not only object of …

Scientific and Ethical Discipline in Clinical Trials on Acute Leukemia G. MATHE Institut de Cancerologie ct d’Immunogenetique "’, Hi’ipital Paul-Brousse "."", Villejuif/France Cli …

G. MATHE and R. K. OLDHAM’~ Institut de Cancerologie et d’Immunogem!tique, Hopital Paul Brousse, Villejuif Since the last war, cancer chemotherapy has been the object of very intensive and expensive …

I would like to thank all my co-workers who have collaborated with me, from 1963 until now, in biological and clinical research in the field of cancer active immunotherapy, of its immuno- prevention …

Fresh living Bacillus Calmette-Guerin (Be G), injected i.v. into (C57BI/ 6x DBA/2)FI mice, activated peritoneal macrophages rendering them highly cytotoxic for tumor cells in vitro. This cytotoxic ac …

…

We have studied 24 cases of secondarily leukemic (stage V) lymphosarcoma (LS), 31 cases of "d’emblee" leukemic LS, and ten cases of lymphoid leukemic neoplasias transitional between "d …

P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year …

…

…

…

The impressive advances in all branches of medical science during the first half of this century with the discovery of many chemotherapeutic or immunogenic agents gave rise to brilliant achievements …